⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX INVESTMENT: MoonLake Immunotherapeutics Investors with Losses may have Rights in Securities Class Action – Contact BFA Law by December 15 Deadline
globenewswire.com
MLTX
TSLA
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
MoonLake Immunotherapeutics' (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate -- Hagens Berman
prnewswire.com
MLTX
MLTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – MLTX
globenewswire.com
MLTX
Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
globenewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
globenewswire.com
MLTX
MLTX SECURITIES ALERT: BFA Law Notifies MoonLake Immunotherapeutics Shareholders of Pending Securities Fraud Class Action and Upcoming December 15 Deadline
newsfilecorp.com
MLTX
Pomerantz LLP Issues Important Reminder to Investors in MoonLake Immunotherapeutics of Class Action Lawsuit – MLTX
accessnewswire.com
MLTX
MLTX DEADLINE: MoonLake Immunotherapeutics Investors are Encouraged to Act before the Upcoming December 15 Deadline - Contact BFA Law if You Lost Money
accessnewswire.com
MLTX
TSLA
MoonLake Immunotherapeutics (MLTX) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of December 15, 2025 Deadline
accessnewswire.com
MLTX